Colorectal cancer (metastatic) - cetuximab (terminated appraisal)
Cetuximab for the treatment of metastatic colorectal cancer following failure of oxaliplatin-containing chemotherapy
Summary
NICE is unable to recommend the use in the NHS of cetuximab for the treatment of colorectal cancer following failure of oxaliplatin-containing chemotherapy because no evidence submission was received from the manufacturer or sponsor of the technology.
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA150
Issued: June 2008
How this guidance was produced